Amoxycillin IP 500mg + Clavulanic Acid IP 125mg

Moxzar CV 625 Tablets by Amista Labs serve as a widely prescribed, broad-spectrum antibiotic for the effective treatment of various bacterial infections. This powerful combination contains Amoxycillin IP 500 mg and Clavulanic Acid IP 125 mg, which work synergistically to combat both resistant and non-resistant bacterial strains. Healthcare professionals commonly recommend Moxzar CV 625 for its proven efficacy, strong safety profile, and wide therapeutic coverage.

Take Moxzar CV 625 Tablets strictly as prescribed by a physician. Adults usually take one tablet two to three times daily, depending on the type and severity of the infection. Swallow the tablet whole with water, preferably at the start of a meal to improve absorption and reduce gastric discomfort. Complete the full course of treatment even if symptoms improve earlier to prevent antibiotic resistance.

Patients generally tolerate Moxzar CV 625 well when they use it as directed. Some patients may experience mild gastrointestinal disturbances such as nausea, vomiting, diarrhea, or abdominal discomfort. In rare cases, patients—especially those with a history of penicillin allergy—may develop allergic reactions like skin rashes or hypersensitivity. Use Moxzar CV 625 cautiously in patients with liver or kidney disorders, and seek medical advice before use during pregnancy or breastfeeding.

Store Moxzar CV 625 Tablets in a cool, dry place away from direct sunlight and moisture. Keep the medicine out of the reach of children. Manufacturers supply the tablets in blister packaging to ensure stability, hygiene, and accurate dosing.